Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice

Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency

(2010) Laurie Schubert et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Hypophosphatemia induced by intravenous administration of saccharated ferric oxide

(2009) Yuichiro Shimizu et al.   BONE

Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*

(2009) Yukiko Aono et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study

(2009) Belinda J. Schouten et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: Drug effects on acetic acid-depressed locomotor activity in ICR mice

(2009) Glenn W. Stevenson et al.   LIFE SCIENCES

Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin Protein

(2008) Dejia Li et al.   AMERICAN JOURNAL OF PATHOLOGY

Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets

(2008) U. S. Alon et al.   Clinical Journal of the American Society of Nephrology

An Actn3 knockout mouse provides mechanistic insights into the association between  -actinin-3 deficiency and human athletic performance

(2008) D. G. MacArthur et al.   HUMAN MOLECULAR GENETICS

Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23

(2008) Yuji Yamazaki et al.   JOURNAL OF BONE AND MINERAL RESEARCH